Mulberroside a protects against ischemic impairment in primary culture of rat cortical neurons after oxygen-glucose deprivation followed by reperfusion

Journal of Neuroscience Research

Volumn 92, Issue 7, 2014, Pages 944-954

  Wang, Cai Ping ^a   Zhang, Lu Zhong ^a   Li, Gui Cai ^a   Shi, Yun wei ^a   Li, Jian Long ^a   Zhang, Xiao Chuan ^a   Wang, Zhi Wei ^a,b   Ding, Fei ^a   Liang, Xin Miao ^a,c  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Apoptosis; Inflammation; Ischemia; Mulberroside A; Neuroprotection

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MULBERROSIDE A; NIMODIPINE; STILBENE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CELL RECEPTOR; CYTOKINE; DISACCHARIDE; GLUCOSE; NEUROPROTECTIVE AGENT; NOD-LIKE RECEPTOR 3, RAT;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL EMBRYO; APOPTOSIS; BRAIN CORTEX; CELL CULTURE; CELL HYPOXIA; CELL SURVIVAL; CYTOLOGY; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CASPASE 1; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYTOKINES; DISACCHARIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; GLUCOSE; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; STILBENES;

EID: 84900426028     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23374     Document Type: Article

References (53)

1. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. 2009. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276:13-26.
2. Andrabi SA, Spina MG, Lorenz P, Ebmeyer U, Wolf G, Horn TF. 2004. Oxyresveratrol (trans-2, 3', 4, 5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Res 1017:98-107.
3. Ban JY, Cho SO, Choi SH, Ju HS, Kim JY, Bae K, Song KS, Seong YH. 2008. Neuroprotective effect of Smilacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo. J Pharmacol Sci 106:68-77.
4. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA. 2001. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev 21:129-145.
5. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787-791.
6. Brandenburg LO, Kipp M, Lucius R, Pufe T, Wruck CJ. 2010. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm Res 59:443-450.
7. Breuer C, Wolf G, Andrabi SA, Lorenz P, Horn TF. 2006. Blood-brain barrier permeability to the neuroprotectant oxyresveratrol. Neurosci Lett 393:113-118.
8. Brough D, Rothwell NJ. 2007. Caspase-1-dependent processing of pro-interleukin-1 beta is cytosolic and precedes cell death. J Cell Sci 120:772-781.
9. Brough D, Tyrrell PJ, Allan SM. 2011. Regulation of interleukin-1 in acute brain injury. Trends Pharmacol Sci 32:617-622.
10. Broughton BRS, Reutens DC, Sobey CG. 2009. Apoptotic mechanisms after cerebral ischemia. Stroke 40:E331-E339.
11. Buck BH, Liebeskind DS, Saver JL, Bang OY, Yun SW, Starkman S, Ali LK, Kim D, Villablanca JP, Salamon N, Razinia T, Ovbiagele B. 2008. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 39:355-360.
12. Cao Q, Qian M, Wang XF, Wang B, Wu HW, Zhu XJ, Wang YW, Guo J. 2011. Negative feedback regulation of Raf/MEK/ERK cascade after sublethal cerebral ischemia in the rat hippocampus. Neurochem Res 36:153-162.
13. Chang LW, Juang LJ, Wang BS, Wang MY, Tai HM, Hung WJ, Chen YJ, Huang MH. 2011. Antioxidant and antityrosinase activity of mulberry (Morus alba L.) twigs and root bark. Food Chem Toxicol 49:785-790.
14. Chung KO, Kim BY, Lee MH, Kim YR, Chung HY, Park JH, Moon JO. 2003. In-vitro and in-vivo anti-inflammatory effect of oxyresveratrol from Morus alba L. J Pharm Pharmacol 55:1695-1700.
15. Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M. 2013. Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PloS One 8:e55375.
16. Dinarello CA. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550.
17. Eder C. 2009. Mechanisms of interleukin-1beta release. Immunobiology 214:543-553.
18. Goldmann T, Tay TL, Prinz M. 2013. Love and death: microglia, NLRP3 and the Alzheimer's brain. Cell Res 23:595-596.
19. Guo YL, Xu XY, Li Q, Li Z, Du F. 2010. Anti-inflammation effects of picroside 2 in cerebral ischemic injury rats. Behav Brain Funct 6:43-53.
20. Hao JL, Li YF, Li RS. 2013. A novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure. Med Hypoth 80:463-465.
21. Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, Malfertheiner M, Kohrmann M, Potrovita I, Maegele I, Beyer C, Burke JR, Hasan MT, Bujard H, Wirth T, Pasparakis M, Schwaninger M. 2005. IKK mediates ischemia-induced neuronal death. Nat Med 11:1322-1329.
22. Hur J, Kim S, Lee P, Lee YM, Choi SY. 2013. The protective effects of oxyresveratrol imine derivative against hydrogen peroxide-induced cell death in PC12 cells. Free Rad Res 47:212-218.
23. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90-94.
24. Ishizuka F, Shimazawa M, Umigai N, Ogishima H, Nakamura S, Tsuruma K, Hara H. 2013. Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice. Eur J Pharmacol 703:1-10.
25. Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
26. Katsube T, Yamasaki M, Shiwaku K, Ishijima T, Matsumoto I, Abe K, Yamasaki Y. 2010. Effect of flavonol glycoside in mulberry (Morus alba L.) leaf on glucose metabolism and oxidative stress in liver in diet-induced obese mice. J Sci Food Agr 90:2386-2392.
27. Kim JK, Kim M, Cho SG, Kim MK, Kim SW, Lim YH. 2010. Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition. J Ind Microbiol Biot 37:631-637.
28. Kriz J. 2006. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol 18:145-157.
29. Lanzillotta A, Pignataro G, Branca C, Cuomo O, Sarnico I, Benarese M, Annunziato L, Spano P, Pizzi M. 2013. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. Neurobiol Dis 49:177-189.
30. Lee YJ, Choi DH, Kim EJ, Kim HY, Kwon TO, Kang DG, Lee HS. 2011. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am J Chinese Med 39:39-52.
31. Lindsberg PJ, Grau AJ. 2003. Inflammation and infections as risk factors for ischemic stroke. Stroke 34:2518-2532.
32. Liu L, Zhang R, Liu K, Zhou H, Yang X, Liu X, Tang M, Su J, Dong Q. 2009. Tissue kallikrein protects cortical neurons against in vitro ischemia-acidosis/reperfusion-induced injury through the ERK1/2 pathway. Exp Neurol 219:453-465.
33. Lorenz P, Roychowdhury S, Engelmann M, Wolf G, Horn TF. 2003. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide Biol Chem 9:64-76.
34. Maddahi A, Povlsen GK, Edvinsson L. 2012. Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway. J Neuroinflamm 9:274-290.
35. Mei M, Ruan JQ, Wu WJ, Zhou RN, Lei JPC, Zhao HY, Yan R, Wang YT. 2012. In vitro pharmacokinetic characterization of mulberroside A, the main polyhydroxylated stilbene in mulberry (Morus alba L.), and its bacterial metabolite oxyresveratrol in traditional oral use. J Agr Food Chem 60:2299-2308.
36. Naowaboot J, Pannangpetch P, Kukongviriyapan V, Kongyingyoes B, Kukongviriyapan U. 2009. Antihyperglycemic, antioxidant and antiglycation activities of mulberry leaf extract in streptozotocin-induced chronic diabetic rats. Plant Food Hum Nutr 64:116-121.
37. Nayak AR, Kashyap RS, Kabra D, Purohit HJ, Taori GM, Daginawala HF. 2012. Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome. Ann Indian Acad Neurol 15:181-185.
38. Noshita N, Sugawara T, Hayashi T, Lewen A, Omar G, Chan PH. 2002. Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J Neurosci 22:7923-7930.
39. Piao SJ, Qu GX, Qiu F. 2006. Chemical constituents of the water extract from mori cortex. Chinese J Med Chem 16:40-45.
40. Price CJS, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, Lynch A, Xuereb JH, Fryer T, Guadagno JV, Warburton EA. 2004. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke-an imaging based study. Stroke 35:1659-1664.
41. Qin X, Sun ZQ, Zhang XW, Dai XJ, Mao SS, Zhang YM. 2013. TLR4 signaling is involved in the protective effect of propofol in BV2 microglia against OGD/reoxygenation. J Physiol Biochem doi: 10.1007/s13105-013-0247-6.
42. Qiu F, Komatsu K, Saito K, Kawasaki K, Yao X, Kano Y. 1996. Pharmacological properties of traditional medicines. XXII. Pharmacokinetic study of mulberroside A and its metabolites in rat. Biol Pharm Bull 19:1463-1467.
43. Savage CD, Lopez-Castejon G, Denes A, Brough D. 2012. NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front Immunol 3:288.
44. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821-832.
45. Song N, Pang W, Yang H, Tan L, Fu J, Li H, Jiang Y. 2012. Primary study on protective effect of mulberry extracts on Abeta25-35-induced PC12 cells injury. J Hygiene Res 41:925-929.
46. Svensson C, Part K, Kunnis-Beres K, Kaldmae M, Fernaeus SZ, Land T. 2011. Pro-survival effects of JNK and p38 MAPK pathways in LPS-induced activation of BV-2 cells. Biochem Biophys Res Commun 406:488-492.
47. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H. 2001. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2:222-228.
48. Traini C, Pedata F, Cipriani S, Mello T, Galli A, Giovannini MG, Cerbai F, Volpini R, Cristalli G, Pugliese AM. 2011. P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase 1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro. Eur J Neurosci 33:2203-2215.
49. Venna VR, Weston G, Benashski SE, Tarabishy S, Liu FD, Li J, Conti LH, McCullough LD. 2012. NF-kappa B contributes to the detrimental effects of social isolation after experimental stroke. Acta Neuropathol 124:425-438.
50. Wanderer AA. 2008. Ischemic-reperfusion syndromes: biochemical and immunologic rationale for IL-1 targeted therapy. Clin Immunol 128:127-132.
51. Wang CP, Wang Y, Wang X, Zhang X, Ye JF, Hu LS, Kong LD. 2011. Mulberroside a possesses potent uricosuric and nephroprotective effects in hyperuricemic mice. Planta Med 77:786-794.
52. Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, Wei WL, MacDonald JF, Wemmie JA, Price MP, Welsh MJ, Simon RP. 2004. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118:687-698.
53. Xu YY, Zhang Q, Yu S, Yang YM, Ding F. 2011. The protective effects of chitooligosaccharides against glucose deprivation-induced cell apoptosis in cultured cortical neurons through activation of PI3K/Akt and MEK/ERK1/2 pathways. Brain Res 1375:49-58.